Evicenter
P&T meetings

Deramiocel

Duchenne muscular dystrophy

Also known as CAP-1002
Launch
Not announced
92 sources

Section 6 of 6

References

92 sources

  1. Aminzadeh et al. (2018) (opens in a new tab)
  2. Aminzadeh et al. (2026) (opens in a new tab)
  3. Andrews et al. (2018) (opens in a new tab)
  4. Audhya et al. (2023) (opens in a new tab)
  5. Avila-Smirnow et al. (2025) (opens in a new tab)
  6. Bever et al. (2026) (opens in a new tab)
  7. Bourke et al. (2022) (opens in a new tab)
  8. Broomfield et al. (2024) (opens in a new tab)
  9. Capricor Therapeutics (2017) (opens in a new tab)
  10. Capricor Therapeutics (2018) (opens in a new tab)
  11. Capricor Therapeutics (2019) (opens in a new tab)
  12. Capricor Therapeutics (2019) (opens in a new tab)
  13. Capricor Therapeutics (2025) (opens in a new tab)
  14. Capricor Therapeutics (2025) (opens in a new tab)
  15. Capricor Therapeutics (2025) (opens in a new tab)
  16. Capricor Therapeutics (2026) (opens in a new tab)
  17. Capricor Therapeutics (2026) (opens in a new tab)
  18. Capricor Therapeutics (2026) (opens in a new tab)
  19. Capricor Therapeutics (2026) (opens in a new tab)
  20. Capricor Therapeutics (2026) (opens in a new tab)
  21. Capricor Therapeutics (2026) (opens in a new tab)
  22. Capricor Therapeutics (2026) (opens in a new tab)
  23. Capricor Therapeutics (2026) (opens in a new tab)
  24. Capricor Therapeutics (2026) (opens in a new tab)
  25. Capricor Therapeutics (2026) (opens in a new tab)
  26. Capricor Therapeutics AAN presentation (2026) (opens in a new tab)
  27. Capricor Therapeutics complaint (2026) (opens in a new tab)
  28. Capricor Therapeutics FDA Advisory Committee briefing document (2026) (opens in a new tab)
  29. Capricor Therapeutics Form 10-K (2020) (opens in a new tab)
  30. Capricor Therapeutics Form 10-K (2026) (opens in a new tab)
  31. Capricor Therapeutics Form 10-Q (2026) (opens in a new tab)
  32. Capricor Therapeutics Form 8-K (2026) (opens in a new tab)
  33. Capricor Therapeutics HOPE-2 protocol (2019) (opens in a new tab)
  34. Capricor Therapeutics HOPE-2 statistical analysis plan (2020) (opens in a new tab)
  35. Capricor Therapeutics HOPE-2-OLE statistical analysis plan (2024) (opens in a new tab)
  36. Capricor Therapeutics HOPE-OLE protocol (2018) (opens in a new tab)
  37. Capricor Therapeutics HOPE-OLE statistical analysis plan (2019) (opens in a new tab)
  38. Capricor Therapeutics MDA presentation (2026) (opens in a new tab)
  39. Capricor Therapeutics PPMD presentation (2026) (opens in a new tab)
  40. CDC (2009) (opens in a new tab)
  41. Crisafulli et al. (2020) (opens in a new tab)
  42. DMD Care Considerations Working Group (2018) (opens in a new tab)
  43. DMD Care Considerations Working Group (2018) (opens in a new tab)
  44. DMD Care Considerations Working Group (2018) (opens in a new tab)
  45. FDA (2024) (opens in a new tab)
  46. FDA (2025) (opens in a new tab)
  47. FDA briefing document (2026) (opens in a new tab)
  48. FDA presentation (2026) (opens in a new tab)
  49. Gandolla et al. (2020) (opens in a new tab)
  50. Gillman et al. (2025) (opens in a new tab)
  51. Iannaccone et al. (2026) (opens in a new tab)
  52. Innis et al. (2025) (opens in a new tab)
  53. Kariyawasam et al. (2022) (opens in a new tab)
  54. Klimchak et al. (2021) (opens in a new tab)
  55. Landfeldt et al. (2014) (opens in a new tab)
  56. Landfeldt et al. (2016) (opens in a new tab)
  57. Landfeldt et al. (2017) (opens in a new tab)
  58. Landfeldt et al. (2018) (opens in a new tab)
  59. Landfeldt et al. (2020) (opens in a new tab)
  60. Landfeldt et al. (2026) (opens in a new tab)
  61. Lempriere (2022) (opens in a new tab)
  62. Li et al. (2025) (opens in a new tab)
  63. Mayhew et al. (2013) (opens in a new tab)
  64. Mayhew et al. (2020) (opens in a new tab)
  65. McDonald et al. (2022) (opens in a new tab)
  66. McDonald et al. (2022) (opens in a new tab)
  67. McDonald et al. (2022) (opens in a new tab)
  68. McDonald et al. (2023) (opens in a new tab)
  69. McDonald et al. (2024) (opens in a new tab)
  70. McDonald et al. (2025) (opens in a new tab)
  71. McDonald et al. (2026) (opens in a new tab)
  72. MedlinePlus Genetics (opens in a new tab)
  73. Muscular Dystrophy Association (opens in a new tab)
  74. Pane et al. (2014) (opens in a new tab)
  75. Pane et al. (2018) (opens in a new tab)
  76. PharmacoEconomics–Open (2026) (opens in a new tab)
  77. Quinlivan et al. (2021) (opens in a new tab)
  78. Rogers et al. (2019) (opens in a new tab)
  79. Rogers et al. (2025) (opens in a new tab)
  80. Scavina et al. (2026) (opens in a new tab)
  81. Smith et al. (2025) (opens in a new tab)
  82. Soslow (2026) (opens in a new tab)
  83. Soslow et al. (2023) (opens in a new tab)
  84. Strober et al. (2026) (opens in a new tab)
  85. Szabo et al. (2020) (opens in a new tab)
  86. Tang and Yokota (2024) (opens in a new tab)
  87. Taylor et al. (2019) (opens in a new tab)
  88. Taylor et al. (2019) (opens in a new tab)
  89. Taylor et al. (2019) (opens in a new tab)
  90. University of California, Davis (2025) (opens in a new tab)
  91. University of California, Davis (2026) (opens in a new tab)
  92. Yip et al. (2026) (opens in a new tab)